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I - ABSTRACT  
 
Purpose: Review the literature of MAT for the treatment of pediatric glaucoma. Methods: 
Literature review from inception to January 2020 performed using an electronic database 
search on PubMed (MEDLINE) and Cochrane Central Register of Controlled Trials 
(CENTRAL). Data retrieved from the articles included patient’s characteristics, IOP, glaucoma 
medication’s number, surgical success rate, failure causes, intra and postoperative 
complications. Results: Eleven studies were included in the review, 8 were MAT case series 
and 3 were RCT, of which 10 were comparative studies (between MAT and 
goniotomy/CT/trab-trab). Five studies included only patients with PCG and six studies 
included patients with PCG and/or SCG. Analysis of 507 eyes of 423 patients were included, 
MAT was performed in 305 eyes. of which 197 eyes (64.7%) underwent complete canalization 
and 108 eyes (35.4%) only partial SC canalization. In 31 eyes (10.2%) MAT was not 
technically possible with conversion to CT. The average age at the time of surgery was 
25.7±15.0 months and the mean time of follow was 13.0±8.5 months. Postoperative IOP and 
number of glaucoma medications at 24 follow-up months (11.5±3.4mmHg, 0.3±0.6 
medications) were significantly lower in comparison to preoperative values (29.6±6.4mmHg, 
2.0±0.9 medications). The average CS rate was 75.0% and 65.5% at12 and 24 months of 
follow-up, respectively, and the mean QS rate was 86.8% and 83.9%, respectively. In the eyes 
that underwent MAT, 46 failed, most of them (n =19 eyes, 41.3%) due to need for additional 
glaucoma surgery. The most common intra and/or postoperative MAT complication was 
hyphema. Conclusions: MAT achieved significant pressure-lowering effects with minimal 
complications in the early postoperative course (up to 24 months) and a reduction in medication 
use, in pediatric glaucoma (PCG and/or SCG), not only as an initial intervention but also in 
patients with previous surgeries. It can be successfully used to catheterize SC in most cases. It 
represents a reasonable choice of initial and repeat surgical treatment of pediatric glaucoma. 
Further research is warranted to determine the long-term success and safety of this procedure.  
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I - RESUMO  
 
Objetivo: Revisão da literatura da trabeculotomia assistida por microcateter iluminado (MAT) 
no tratamento do glaucoma pediátrico. Métodos: Realizou-se uma revisão da literatura até 
Janeiro de 2020, utilizando a pesquisa eletrónica na PubMed (MEDLINE) e Cochrane Central 
Register of Controlled Trials (CENTRAL). A informação de cada artigo for compilada com 
base na abordagem terapêutica, tendo sido depois avaliada e interpretada criticamente.  A 
análise dos artigos incluiu características do paciente, pressão intraocular (PIO), número de 
medicamentos para glaucoma, taxa de sucesso cirúrgico, causas de falha, complicações intra e 
pós-operatórias. Resultados: Foram incluídos onze estudos na revisão: oito MAT casos-serie e 
três ensaios clínicos randomizados, dos quais dez são estudos comparativos (entre MAT e 
goniotomia/CT/trab-trab). Cinco estudos incluíram apenas pacientes com PCG e seis estudos 
incluíram pacientes com PCG e/ou SCG. Foi incluída a análise de 507 olhos de 423 pacientes, 
sendo que a MAT foi realizada em 305 olhos, dos quais 197 olhos (64.7%) foram submetidos 
à canalização completa e 108 olhos (35.4%) apenas a canalização. Em 31 olhos (10.2%), a 
MAT não foi tecnicamente possível ser realizada, sendo realizada conversão para CT. A idade 
média no momento da cirurgia foi de 25.7±15.0 meses e o seguimento médio entre estudos foi 
de 13.0±8.5 meses. A PIO no pós-operatório e o número de medicamentos aos 24 meses de 
pós-operatório (11.5±3.4mmHg, 0.3±0.6 medicamentos) foram significativamente menores 
que os valores pré-operatórios (29.6±6.4mmHg, 2.0±0.9 medicamentos). A taxa média de CS 
foi de 75.0% e 65.5% aos 12 e 24 meses, respetivamente e a taxa média de QS foi de 86.8% e 
83.9% aos 12 e 24 meses, respetivamente. Nos olhos submetidos à MAT, 46 falharam, a 
maioria (n=19 olhos, 41.3%) devido à necessidade de cirurgia adicional. A complicação intra 
e/ou pós-operatória mais comum na MAT foi o hifema. Conclusões: A MAT obteve efeitos 
significativos na redução da PIO com complicações mínimas no pós-operatório precoce (até 
24 meses) e redução no uso de medicamentos no glaucoma pediátrico (PCG e/ou SCG), não 
apenas como intervenção inicial, como em pacientes com cirurgias prévias. Pode ser utilizado 
com sucesso para cateterizar o canal de Schlemm na maioria dos casos. Representa uma escolha 
razoável de tratamento cirúrgico inicial e repetido do glaucoma pediátrico. Serão necessárias 
mais pesquisas para determinar o sucesso e a segurança a longo prazo deste procedimento. 
Palavras-chave: glaucoma pediátrico, glaucoma congénito, pressão intraocular, trabeculotomia 
360o, microcateter iluminado. 
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II - INTRODUCTION 
 
Glaucoma in children is a rare, potentially blinding condition characterized by elevated IOP 
with related damage to the eye and is caused by a diverse group of conditions. Clinical 
presentation can vary because, depending on the age of onset, elevated IOP can affect the whole 
eye and not just the optic nerve as in adults. The goal of the treatment is to provide a lifetime 
of vision if possible. Successful control of IOP is crucial in achieving this goal but can be 
challenging, especially when surgery is necessary. The correction of ametropia and amblyopia 
therapy is also vital to maximize visual function.1 
Glaucoma from any cause in a neonate or infant classically presents with a triad of lacrimation, 
blepharospasm, and photophobia due to corneal edema from elevated IOP. These signs are not 
entirely specific but are very suggestive of glaucoma and may appear before the hazy cornea 
and characteristic buphthalmos become obvious. Buphthalmos refers to the ocular enlargement 
caused by elevated IOP. The potential for corneal enlargement usually ceases by the age of 3 
years, although the sclera remains deformable until around 10 years of age. Moreover, as the 
IOP rises, Descemet membrane eventually ruptures, with one edge usually retracting as a scroll 
to form a ridge known as Haab strae. As the underlying endothelium is torn, localized or 
diffuse corneal edema results from aqueous influx into the stroma causing a sudden cloudiness. 
With successful lowering of IOP, corneal clouding typically begins clearing first in the 
periphery. Photophobia may still persist with normalization of IOP due to the Haab striae. 
Beyond the age of 3 years, children are more likely to present with progressive myopia, 
strabismus, or after having failed vision testing.1 
Although medical therapy is still the mainstay for many types of pediatric glaucoma, surgery 
is much more frequently needed than in adult glaucoma for long-term control because of the 
refractory nature of the disease in children. 1 
 
II.A – DIAGNOSTIC CRITERIA AND CLASSIFICATION OF PEDIATRIC GLAUCOMA  
In 2013 the Consensus Group for Childhood Glaucoma from the WGA has developed the 
diagnostic criteria and a classification system from pediatric glaucoma (Figure 1). The 
diagnosis is made if two or more criteria are met including ocular hypertension, optic nerve 
cupping, Haab striae, increased corneal diameter or axial length and/or visual field defect. 
Generally, this condition can be classified as: primary where there is only a developmental 
abnormality of the iridocorneal angle; and secondary where aqueous outflow is reduced by 
congenital or acquired ocular diseases or systemic disorders.2 
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Primary glaucoma in childhood can be defined as primary congenital glaucoma (PCG) or 
juvenile-onset open angle glaucoma (JOAG), depending on the age of disease onset and angle 
dysgenesis. The pathogenesis of the PCG is that of an isolated trabeculodysgenesis, which 
leads to a reduced aqueous outflow and raised IOP during the early years of life.  
Secondary pediatric glaucoma (SPG) can either present at birth as a result of developmental 
ocular anomalies (nonacquired form) or develop later in childhood (acquired form). Conditions 
such as in iridocorneal dysgenesis: Peters anomaly, Axenfeld-Rieger syndrome, and aniridia 
are associated with the nonacquired type of secondary glaucoma in children. Common causes 
of the acquired secondary form include steroid induced, trauma, ocular inflammation, tumors, 
retinopathy of prematurity and following cataract surgery.1 
 
II.B – PRINCIPLES OF MANAGEMENT 
Any suspicion of glaucoma in a child should always be treated seriously and with urgency to 
minimize visual impairment. The aim of the initial assessment is to make a diagnosis of 
glaucoma and determine the type (primary or secondary) which is necessary in determining 
management. 
It is important to begin the examination by assessing the patient’s overall appearance and visual 
behavior including the presence or absence or nystagmus or strabismus and the determination 
of visual acuity and refraction. Subsequently IOP measurements should be undertaken. In 
children measuring IOP can be challenging because it can be influenced by many factors, e.g. 
type of anesthetic, instrumentation, corneal thickness and opacities. The reference standard for 
measuring IOP is with GAT. More recently, the iCare® portable rebound tonometer has 
become available for IOP measurement without the instillation of topical anesthetic drops in 
both supine and upright positions. It is well tolerated and is thought to have a similar reliability 
to TonoPen®, both of which have a tendency to overestimate IOP compared to GAT.3,4 
In the anterior segment examination, the cornea must be examined for the presence of 
posterior embryotoxon, edema, opacities and Haab striae. Excluding primary corneal 
pathology is important, and a useful finding is the absence of corneal or ocular enlargement. 
The corneal diameter should be measured, and it was considered abnormal if horizontally ≥11 
mm in a newborn and ≥ 12 mm in an infant ˂1 year and ≥13mm after 12 months of age. Serial 
corneal diameter measurements are useful in monitoring glaucoma progression until the age of 
3 years. An increasing corneal diameter may indicate inadequate control of IOP requiring 
further treatment.42 CCT influences the accuracy of tonometry. Patients with PCG and JOAG 
have thinner corneas and in theory a tendency for under reading the IOP. Conversely, an 
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increase in corneal thickness, as is found in patients with aphakia and aniridia, may lead to an 
overestimation of IOP. Regardless of corneal thickness, the emphasis remains on the optic disc 
appearance.1 Detecting iris or pupil abnormalities or co-existing lens opacities is important as 
the latter may require treatment and influence the choice of glaucoma surgery.1 Gonioscopy is 
crucial in making the correct diagnosis, which determines the most appropriate operation and 
prognosis. 
Finally, the posterior segment examination should be performed.  The appearance of the 
optic disc is by far the most important and sensitive parameter for both diagnosis and 
progression of glaucoma, as it is influenced neither by anesthesia nor the effect of growth. 
Richardson2 noted a cup:disc ratio (C/D) of greater than 0.3 in only 3% of 468 normal 
Caucasian newborn eyes, in contrast to Shaffer who found a C/D of greater than 0.3 in 61% of 
85 eyes in infants less than 1 year with congenital glaucoma.3 A C/D > 0.3 in a Caucasian 
infant less than 1 year or >0.5 in a child and disc asymmetry should greatly increase suspicion 
of glaucoma. An increase in disc cupping is definite evidence of poorly controlled glaucoma 
and the need for further treatment, regardless of IOP measurement obtained. Disc cupping in 
children can be reversible if IOP reduction occurs before irreversible nerve atrophy, and it is 
more likely in the younger the child. It is thought to represent a “pre-laminar” phenomenon 
where reversible laminar bowing is associated with compression and stretching of the pre-
laminar neural tissue. Once the IOP is normal, the compression is relieved allowing the laminar 
to move anteriorly, “filling in” the cup. However, despite disc cupping reversal, retinal nerve 
fiber layer thinning may persist postoperatively.7 The remainder of the fundus should be 
examined for any associated abnormalities such as foveal hypoplasia associated with aniridia, 
choroidal hemangiomas in Sturge–Weber syndrome, and pigmentary retinopathy associated 
with rubella.1 
Axial length (AL) measurement with ultrasound is useful for baseline assessment; if it is 
outside normal limits it is strongly suggestive of glaucoma. Serial AL can be valuable in 
children for detecting progression when the eye is still distensible. In glaucoma, AL 
measurements are usually asymmetrical, in contrast to megalocornea and normal eyes. There 
is usually a decrease in AL following successful lowering of IOP.  
Visual fields are usually possible around the age of 7–8 years, but there is a learning curve. 
Visual field defects must be reproducible, so defects must be confirmed by repeating the test. 
Furthermore, the defects must correspond to the optic disc appearance. OCT may be used since 
a young age to detect and monitor RNFL and macular ganglion cell layer thinning.8 
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II.C - TREATMENT OF PEDIATRIC GLAUCOMA 
Managing glaucoma in childhood is one of the greatest challenges in the field of glaucoma. 
Medications play a vital role in management, as they are first-line therapy for most glaucomas; 
however, sustained efficacy is less likely in neonates and infants, especially those with PCG. 
Medications are frequently needed to lower the IOP before surgery and are often required as 
adjunctive therapy after partially successful. Most children with glaucoma will require surgery 
in their lifetime. However, surgery is challenging, largely because of its greater potential for 
failure and complications as compared to adults.1 No treatment is curative, so lifelong follow-
up is necessary to ensure IOP control and to detect complications, which can occur at any time, 
even after years of stability. Furthermore, parents and, later, patients should be warned that 
minor blunt trauma in buphthalmic eyes may result in severe visual loss. Protective eyewear 
should be recommended, especially in monocular patients. The first line treatment for children 
includes prostaglandin agonists, carbonic anhydrase inhibitors and beta-blockers. In young 
children (˂8 years-old) alpha-adrenergic agonists, such as brimonidine, can cause central 
nervous system depression with resultant somnolence, hypotension, bradycardia, and 
respiratory difficulty, so this class of hypotensive drops is contra-indicated.1 
 
Goals of the Surgery 
Although for every glaucoma procedure the most immediate objective is the reduction of 
harmful elevated IOP, in children other aims need to be kept in mind when deciding which 
procedure to perform and when to do it. With children we are running against time because the 
sooner the child develops clear media, improved visual acuity and binocularity, the better. It is 
well known that in spite of adequate normalization of IOP, many elements hamper the 
development of a normal vision in these children; however, aiming at preserving or restoring 
the best possible visual function is an important final goal.3,4 
Glaucoma surgery is classified in four broad groups: 1) angle surgery, 2) non penetrating 
glaucoma surgery, 3) glaucoma drainage devices and 4) LASER. 
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1.1 ANGLE SURGERY 
For pediatric glaucoma the most commonly performed angle surgeries are goniotomy 
(conjunctival sparing) and trabeculotomy (non-conjunctival sparing). Both procedures 
presumably work by allowing a more direct access of aqueous humor into Schlemm’s canal 
and the outflow system. 1,5 Both types of angle surgery have been shown to be effective, there 
is a general preference to use goniotomy in milder cases with clear corneas and trabeculotomy 
and/or combined trabeculotomy with trabeculectomy (trab-trab) in mild-to-severe cases with 
opaque corneas (if the cornea is cloudy enough to preclude a safe goniotomy or when the 
surgeon prefers this technique due to prior training or more experience with the procedure even 
when the cornea is clear). 




Goniotomy is the oldest procedure described for treating congenital glaucoma. Although 
initially used by De Vincentis, in 1893, for all types of glaucomas, Barkan is credited by 
combining it with gonioscopic view, including direct visualization of the angle and giving a 
detailed description of the procedure and reporting its successful use in congenital glaucoma 
in 1938. Modifications allowed to combine goniotomy with the use of the surgical 
microscopes, which were introduced into ophthalmology in the early 1950’s, but routinely used 
in large eye institutions dealing with this disease (such as Moorfields Eye Hospital) until the 
late 1960’s.3 It remains one of the most widely used surgeries for the treatment of the pediatric 
glaucomas because of its efficacy and low complication rate.3 
Goniotomy has the advantages of being brief in execution and atraumatic procedure in 
experienced hands, and it completely spares the conjunctiva so that the success of future 
filtration surgery will not be compromised. Although it requires considerable experience and 
it is surgically challenging. A good view of the angle is paramount and visualization can be 
improved in some cases with preoperative systemic carbonic anhydrase inhibitors, corneal 
epithelial removal, or the use of an endoscope. 1 
The technique consists of performing an incision of trabecular meshwork with a 25G 
goniotomy knife (MVR blade) by direct visualization of the angle with a gonio lens (Koeppe, 
Barkan, Swan-Jacobs and Ritch).3 The trabecular meshwork is engaged just posterior to 
Schwalbe’s line, and the knife is used to make a circumferential incision for 4 to 5 clock hours. 
Care must be taken not to incise too deeply and damage the outer wall of Schlemm’s canal. 
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Often, a cleft with exposure of less pigmented tissue is observed as the incision is made, with 
widening of the angle and posterior movement of the peripheral iris.5 Goniotomy can only treat 
100-120º of the angle at each sitting. Hence, repeating this procedure is often undertaken to 
maximize its surgical results when deemed necessary.1 
Complications  
Goniotomy is commonly complicated by hyphema, which usually resolves without 
intervention over the first postoperative week. Other complications are rare but include 
iridodialysis, peripheral anterior synechiae, cyclodialysis, injury to the crystalline lens, retinal 
detachment and endophthalmitis.5 
Outcomes 
Repeat procedures in untreated portions of the angle may improve pressure control, although 
there are no reliable data correlating the number of degrees treated and surgical success. 
However, overall the success of goniotomy has been reported to attain 80–90% in children 
with PCG who present between 3 months and 1 year of age. In children who present at birth or 
after 12 months of age, the success rate of goniotomy decreases to 30–50%.2,5,6 In Arab 
Countries the success rate of goniotomy is low (~13-52%), therefore Trab-Trab plus mitomycin 
C is usually the primary procedure of choice.3 
 
1.1.2 Trabeculotomy 
Trabeculotomy has historically shown high rates of success for pediatric glaucoma.7 Accurate 
localization of Schlemm canal is the key to successful trabeculotomy. However, abnormally 
stretched limbal anatomy in buphthalmic eyes makes it difficult to identify and it may not be 
found at all in 4–20% of patients, especially if the AC is inadvertently entered before the canal 
is found.9 Controversy regarding which was a better initial procedure (trabeculotomy versus 
goniotomy) exists since the introduction of trabeculotomy and remained for a long time, with 
some authors arguing that trabeculotomy had a better success rate as a single procedure than 
goniotomy.3 
Although trabeculotomy ab externo has the disadvantage of requiring a conjunctival incision, 
its main advantage is that it can be performed easily in eyes with corneal opacity. In addition 
to standard trabeculotomy, there are 2 main variations of trabeculotomy surgery: suture 
trabeculotomy and illuminated microcatheter-assisted trabeculotomy.   
Conventional trabeculotomy is performed with metal trabeculotome instruments, enabling 
approximately 180º of the Schlemm canal to be opened at a single surgical session.5 Burian 
and Smith first described performing 360º suture trabeculotomy in cadaveric eyes in 1960. 
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Then it was modified by Harms (1966) and Dannheim, and McPherson.5 Later, in 1966, Harms 
modified the technique by dissecting a superficial scleral flap similar to the one used in 
trabeculectomy and then making the radial incision to identify Schlemm’s canal and opening 
it with a modified instrument (Harm’s trabeculotome) which had two parallel arms, one to open 
Schlemm’s canal and the other one to guide externally the direction of the trabeculotome.6  
Complications 
As with goniotomy, a frequent complication of trabeculotomy is hyphema, which was mostly 
self-limited and does not require intervention. Other less frequent complications include 
inadvertent filtering blebs, choroidal detachment, iridotomy, injury to the crystalline lens, 
creation of a false passage into the AC, cornea, or suprachoroidal space, and stripping of DM. 
9 
Outcomes 
Success rates of trabeculotomy have been reported in the range of 73–90% in congenital 
glaucoma. As with goniotomy, success rates decrease in PCG that presents at birth or after 12 
months of age, as well as in patients with infantile-onset glaucoma associated with ocular 
and/or systemic abnormalities or aphakic glaucoma.2,5  
 
1.1.3 Modifications to the Goniotomy and Trabeculotomy Procedures 
A) 360º Trabeculotomy with suture 
Beck and Lynch refined trabeculotomy’s technique by using 6-0 prolene suture threaded around 
the entire length of Schlemm’s canal, using 1 or 2 sclera incisions. A direct communication 
between the AC and Schlemm’s canal is created by cannulating the Schlemm’s and then tearing 
through the trabecular meshwork into the AC. The entire angle is incised, thus avoiding 
multiple procedures that may be needed in some cases using conventional trabeculotomy or 
goniotomy, both of which treat only about a third to a half of the angle. Although elegant, this 
360º suture technique can be challenging, with difficulties most often including inability to 
thread the suture to a full 360º angle and an occasional suprachoroidal placement of the suture.9 
As prolene is very rigid with a greater potential for damaging the intraocular structures, more 
recently the same technique using a 4-0 or 5-0 nylon has been used. The progress of the suture 
can be appreciated through use of a gonioprism.10,11 Success rates of 87–92% have been 
reported in cases of PCG < 12 months of age. In childhood glaucoma with a poor prognosis 
(PCG at birth or after 12 months of age, previously failed goniotomy surgery, aphakic 
glaucoma, infantile-onset glaucoma with associated ocular/systemic anomalies) 360° suture 
trabeculotomy has a 2-year success rate of 58–62%.1 
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B) 360º Trabeculotomy assisted with illuminated microcatheter 
In 2010 Sarkisian2 was the first to describe the technique of a 360º trabeculotomy using an 
illuminated flexible microcatheter (iTrack, Ellex, Menlo Park, CA, USA). The lighted tip to 
guide the catheter minimizes potentially devastating inadvertent misdirection into the 
suprachoroidal or subretinal space by verification of the microcatheter location within 
Schlemm’s canal. 
The microcatheter has a 200µm diameter shaft with an atraumatic distal tip of approximately 
250µm in diameter; it has a lumen with a proximal luer lock connector through which 
ophthalmic viscosurgical device (OVD) may be delivered. Therefore, this technique has the 
additional advantage of allowing viscodilation of the SC while it is cannulated (Figure 2). 
 
B1) Ab externo Surgical Technique2 
Beneath a 5mm superonasal conjunctival peritomy, Schlemm’s canal was accessed by creating 
a 4.0x4.0mm flap scleral dissection just posterior to the limbus followed by a radial incision to 
reveal Schlemm’s canal. After creating a small peripheral limbal paracentesis with a 15º blade, 
2 tying forceps were used to grasp the microcatheter, placing the tip in alignment with the 
canal, and the device was advanced into the canal. The light beacon at the tip of the 
microcatheter allows visualization for more accurate placement of the device. When 
catheterizing the canal, the microcatheter has a lumen for fluid delivery for SC viscodilation, 
the general protocol for injection is approximately 4 to 6 mg of OVD injected every 2 clock 
hours of advancement using the OVD injector. 
If a 360º catheterization is achieved, each end of the microcatheter is drawn like a purse-string 
to gently garrote the entire canal inward. If unable to complete a sufficient trabeculectomy, a 
Harms trabeculotome (Rumex Microsurgical Ophthalmic Instruments, St. Petersburg, FL) 
should be used to rupture as much of the canal wall as possible. The procedure is completed 
by closure of the superficial flap and conjunctiva to ensure a water-tight seal that would prevent 
the formation of a filtering bleb (Figure 3).  
 
B2) Ab interno Surgical Technique3 
A 23G needle paracentesis is placed in either the supero or infero-nasal quadrant and the AC 
is filled with OVD. A temporal paracentesis is created with a 15º blade. The microscope and 
the patient’s head should be oriented to allow proper visualization of the nasal angle with a 
Swan-Jacob goniolens. A 1-2 mm goniotomy is created in the nasal angle with a microsurgical 
blade (25G MVR) through a temporal paracentesis. Microsurgical forceps (MST handle and 
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MST MH 23G) are then used to grasp the microcatheter within the AC. The distal tip of the 
microcatheter is inserted into the SC at the goniotomy incision. The microsurgical forceps are 
used to advance the catheter through the canal circumferentially 360º within the AC.  The 
progress of the microcatheter is noted by observing the illuminated tip. The distal tip of the 
microcatheter is advanced in the canal until it reemerges at the opposite side. Upon retrieving 
the distal tip, the catheter tip is externalized from the temporal corneal incision creating the 
first half of the 360° trabeculotomy. Then, traction is placed on the proximal aspect of the 
catheter, thus creating a 360° ab interno trabeculotomy. The OVD is then removed from the 
AC, a 15-40% AC filled with viscoelastic is instilled to help tamponade bleeding from the 
canal and protect against immediate postoperative hypotony.  
In certain cases, the microcatheter cannot be passed 360º in one direction and stops at around 
180-270º. In these cases, a limited trabeculotomy is created by cutting down (ab interno) over 
the catheter at the stopping point. The distal end is retrieved and externalized, thus creating a 
180-270º trabeculotomy. The microcatheter is then passed in the opposite direction through an 
additional 23G needle incision and the remaining trabecular tissue is cleaved. 
 
B3) Ultrasound biomicroscopy – UBM12  
High-resolution UBM can be utilized to visualize the amount of distention placed on TM 
(Figure 4).  This might be useful to correlate the TM distension and the IOP results. A 
semiquantitative grading scale was created to quantify the distension of the TM on a scale of 0 
to 3 based on exemplary images (Figure 5), with 0 equaling no distension and 3 representing 
maximum distension. UBM images are obtained using a system designed for intraoperative 
and office-based anterior segment imaging (iUltrasound, iScience Interventional) to 
characterize preoperative and postoperative anterior angle morphology. Of interest were 
postoperative images collected for all 4 quadrants of the operative eye to assess viscodilation 
of Schlemm’s canal and distension of the trabecular meshwork from the tensioning suture. 
There is a substantial decrease in IOP from mean baseline in eyes with minimal or no trabecular 
distension (grade < 0.5) and a greater one in eyes with measurable distension (grade > 0.5). 
 
C) Gonioscopy-assisted transluminal 360º trabeculotomy (GAAT) 
Recently a minimally invasive ab interno trabeculotomy was described, termed gonioscopy-
assisted transluminal trabeculotomy (GATT). Grover and colleagues11 introduced this 
procedure in 2018. A goniotomy is created in the nasal angle using a 25G MVR blade. A 5-0 
prolene suture (Ethicon) or microcatheter (iTrack) is inserted into the AC (Figure 6). 
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Microsurgical forceps are then used to direct the distal tip of the microcatheter into Schlemm’s 
canal at the goniotomy site. Within the anterior chamber, the microsurgical forceps are used to 
advance the catheter through the canal circumferentially 360º. The distal tip of the catheter, 
once it has circumnavigated the entire canal, is retrieved and externalized, thus creating a 360º 
trabeculotomy (Figure 7). 
Although only a few studies were published reporting the surgical success of GAAT, it has 
shown success in decreasing both IOP and number of glaucoma medications in primary, 
juvenile and secondary open-angle glaucoma, including uveitic, steroid-induced, traumatic, 
pigmentary, and pseudo exfoliation. GATT may even be an effective and safe option for 
patients with refractory glaucoma who have undergone previous incisional surgery 
(trabeculectomy, glaucoma drainage device, trabectome, or endoscopic 
cyclophotocoagulation).13 
Smith et al. described a proposal of modification to the original GATT procedure by replacing 
the initial goniotomy incision of the GATT procedure with an ab interno trabeculectomy 
performed with the trabectome (trabectome-initiated gonioscopy-assisted transluminal 
trabeculotomy -TIGATT). This is an easier method of performing GATT because it provides 
clear visualization into Schlemm’s canal and eases the passing of the microcatheter into the 
canal (Figure 8). The trabectome handpiece (NeoMedix Corporation, Tustin, CA, USA) is 
inserted into the AC via the temporal incision and used to ablate 90º of the nasal trabecular 






Trabeculectomy, involves a surgically formed pathway for aqueous humor between the AC 
and the subconjunctival space. One of the main indications for trabeculectomy is failed angle 
surgery. It may be the primary procedure of choice when: the surgeon has no or limited 
experience with angle surgery; the patient is unlikely to respond sufficiently to angle surgery 
(very early or late presentations); very low target pressures are required (improved cornea 
clarity, advanced disc cupping); and for most secondary glaucomas. One disadvantage of this 
technique is that the superior conjunctival area is utilized, and even after successful surgery, 
with a normal life expectancy, there is a high likelihood that a significant proportion of these 
patients will need further surgery within their lifetimes.  
The decision to perform trabeculectomy with antimetabolites in a child is difficult and requires 
consideration of several factors. Age of the child is a major consideration, as older children 
tend to have a higher success rate and may be able to cooperate more readily with postoperative 
management such as monitoring for bleb leaks and suture release. Older children may also be 
able to communicate symptoms of bleb-related infection and thus have a higher likelihood of 
appropriate treatment.5 Severity and duration of glaucoma are other negative predictive factors 
for success with either surgery.6 Phakic status, avoidance of contact lens use, and social support 
are also factors to consider in surgical decision making.5 
Complications 
Early complications are related to hypotony (shallow or flat AC, hypotony maculopathy, 
choroidal effusion, suprachoroidal hemorrhage) and late complications are associated with thin 
avascular, cystic blebs prone to leakage and potentially blinding infection (including 
blebitis/endophthalmitis), encapsulation of the bleb with resultant IOP elevation and increased 
risk for cataract formation. The most striking difference in complication rates after surgery 
when comparing the adult and pediatric populations is the rate of infection after trabeculectomy 
which are substantial higher, up to 6.7%.9 Another potential difference in trabeculectomy 
postoperative complications between adults and children is the healing response to 
overfiltration. Although hypotony (0%-14.5%) and shallow or flat AC (3.0%-30.0%) are 
common in children, some authors have suggested that the vigorous healing response in 
children may reverse overfiltration quicker compared with adults.9 
Outcomes 
In pediatric patients, the success rate of trabeculectomy without adjunctive antimetabolites is 
30–35%. With the use of adjunctive antimetabolites, the cumulative success rate at 2 years vary 
between 59–90% and reduces to 51-58% at 5 years.1,3,9 
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1.2.1 COMBINED TRABECULOTOMY AND TRABECULECTOMY (TRAB-TRAB) 
This technique was first described by Maul et al in 1980.1 Studies have suggested that the 
principal argument for combined Trab-Trab is a higher chance of success with a single 
operation.3 The intended mechanism of action for combining these two procedures is to gain 
access to dual outflow through Schlemm’s canal and/or the trabeculectomy fistula. In the 
treatment of eyes with PCG, this technique marries the ideology of treating the site of primary 
pathology (i.e. the angle) with the hope of achieving maximal surgical survival in a primary 
filtration surgery. 3 Mostly the technique is used in children with poor prognosis childhood 
glaucoma or prior failed angle surgery. Antimetabolites such as MMC and 5-FU have also been 
used at the site of the scleral flap prior to flap dissection.5 
Complications 
Most ones are similar to the ones described in trabeculotomy and trabeculectomy sections.3 
Outcomes 
Trab-trab has been shown to be potentially more effective than either procedure alone in cases 
of severe PCG, although there has been a lack of prospective comparative data thus far to 
demonstrate this. The results of this procedure have been mostly reported in Middle Eastern 
and Indian populations, where it was used preferentially because it was felt that congenital 
glaucoma did not respond as well to angle surgery as previously described in western 
populations.1,3,5,9,15 
1.3 NON-PENETRATING GLAUCOMA SURGERY 
Viscocanalostomy and deep sclerectomy are newer operations for glaucoma that aim to lower 
IOP by enhancing the natural aqueous outflow channels, while reducing outflow resistance 
located in the inner wall of the SC and the juxtacanalicular TM. Both procedures involve 
fashioning a partial-thickness scleral flap, removing a second layer of sclera deep to the initial 
flap that involves deroofing of the SC, and exposing DM (Figure 9). Aqueous is then allowed 
to percolate through the intact DM window into the intrascleral space. 1 In small series deep 
sclerotomy has a reported success rate between 50-70%. Because of the nonpenetrating nature 
of the surgery, complications commonly seen after trabeculectomy surgery, such as early-
hypotony, cataracts, and long-term complications of filtering blebs including leaks and 
infection, may be reduced or avoided. Difficulties with these procedures in children are that 
they have a thinner and more elastic sclera and variable anatomical features, and it is not always 
possible to identify Schlemm’s canal, all of which make a procedure already technically 
demanding, even more challenging and more likely to be performed at highly specialized 
centers in treating this condition. 3  
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1.4 GLAUCOMA DRAINAGE DEVICE 
For refractory cases after angle surgery the next step would be glaucoma drainage device 
(GDD) implantation. The most common GDD used currently are the Ahmed glaucoma valve 
(AGV, New World Medical Inc., CA, USA)  with  unidirectional flow restriction, which 
theoretically reduces the risk of early hypotony and the Baerveldt glaucoma implant (BGI, 
plate 250mm2 and 350mm2), which is an unrestricted implant (AMO Inc., IL, USA) and so 
requires additional measures to minimize early hypotony.1,16-19 Success rates in published 
studies of GDDs are difficult to compare due to differences in pediatric glaucoma etiologies 
and devices. 
Recently a new technique has been described for using the XEN gel stent (Allergan, Dublin, 
Ireland) as a flow restrictor for the Baerveldt tube. Therefore, precluding early postoperative 
hypotony and reducing corneal endothelial trauma.20 Furthermore a new GDD was introduced, 
the Paul glaucoma implant (Advanced Ophthalmic Innovations Ltd, Singapore). This device 
has the advantage of having a large thin plate as the BGI, however the tube’s internal lumen 
diameter was reduced to one third of the size (125 vs 300µm Paul vs BGI). In theory this might 
also reduce the risk of corneal endothelial trauma and early postoperative hypotony.48 
Outcomes 
At 1–2 year follow–up, many studies report a success of around 80% and this falls to around 
50% in the longer term.36-39 When debating which GDD performs best in children—there is no 
clear superiority of one type of GDD versus another, however the BGI may provide slightly 
better long- term IOP control but the AGV fewer short term complications. 36-39 
Complications 
One of the most common and sight-threatening complications of GDD surgeries in children is 
postoperative hypotony. The risk may be mitigated by reducing aqueous flow with external 
ligation of both flow-restricted and unrestricted implants. Other than hypotony, a wide range 
of complications may occur, including lens touch with cataract formation, corneal touch with 
corneal decompensation, and iris touch with persistent iritis or dyscoria. Moreover, tube 
migration either into the anterior chamber or posteriorly out of the anterior chamber has been 
documented. Tube obstruction from iris, vitreous, hemorrhage, and fibrinous or inflammatory 
membrane can also occur, whereas tube erosion and exposure can lead to infections and 
endophthalmitis. In some cases, GDDs may cause cosmetic or eye motility issues. Tube 
exposure is an important complication in the long term. Early recognition of endophthalmitis 
is extremely important, and most will require emergency removal of tube and plate in order to 
prevent further proliferation of the infection, which can lead to total loss of sight. GDD can 
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reduce endothelial cell density over time, leading to corneal decompensation. Fibrosis and 
encapsulation around the plate remain the main reasons of GDD failure. In contrast with 
trabeculectomy, the advantage of reducing fibrosis with anti-scarring agents has not been 
established in GDD surgeries in pediatric eyes. However, some authors support that after failed 
GDD surgery, repeat GDD surgery with MMC may be successful. After GDD failure, the 
introduction of topical glaucoma medication is considered to be the simplest and lowest risk 
option. Alternatively, needling or surgical revision of the bleb over the plate (capsule excision) 





Cyclodestruction reduces aqueous production. Initially, cyclotherapy demonstrated poor-long 
term outcomes. In the past years, it has been replaced by less destructive LASER 
cyclophotocoagulation. Specially the transcleral diode laser (810nm) in comparison to the 
Nd:YAG KTP laser (532nm), as it is better tolerated and with fewer complications.4 
A major drawback of the transcleral approach is ensuring accurate laser placement in 
buphthalmic eyes with distorted landmarks and hence difficulty in titration of laser energy. 
Endoscopic diode laser allows precise treatment of the ciliary processes, but the disadvantage 
is it requires an intraocular approach and caution is suggested in phakic patients. Transscleral 
diode laser with transillumination of the eye to improve the accuracy of laser placement, and 
avoiding areas of pigmentation, hemorrhage, and scleral thinning. If future GDD surgery is 
planned, the supero-temporal quadrant should be avoided to prevent future scleromalacia. 
Diode laser should be avoided in children with uveitic glaucoma due to poor outcomes and risk 
of chronic hypotony.  
Common indications include treating blind, painful eyes or those with poor visual potential; if 
surgery is technically difficult or impossible for example, severely scarred conjunctiva or if 
there are significant ocular abnormalities. Occasionally it may be useful as a temporizing 
measure, for example, an acute presentation of significantly elevated IOP as occurs following 
trauma, during the hypertensive phase of an Ahmed implant in aphakic/pseudophakic eyes or 
when a definitive procedure must be delayed for example, fellow eye has undergone major 
surgery. 4 
Complications  
Complications associated with diode laser include: hypotony, significant uveitis, phthisis, 
conjunctival burns, uveitis, scleromalacia, scleral perforation, cataract, retinal detachment, and 
loss of vision especially in eyes with two or more treatments or in eyes with pre-existing 
poorvision.3  
Outcomes 
Short-to-medium term outcomes of transscleral diode laser quote over 50% success but with a 
high re-treatment rate and a continuation of medical therapy. Endoscopic diode achieves 
similar results with a lower re-treatment rate.3   
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II.D – POSTOPERATIVE CARE AND FOLLOW-UP 
 
After surgery, all patients should be given topical broad-spectrum antibiotics and topical 
steroids. The main goals are to prevent infection, controlling inflammation and preventing a 
steroid IOP response. 
The patient’s IOP should be treated during the postoperative period according to the surgeon’s 
discretion.  
Postoperative visits: 1 day, 1 week, 2 to 3 weeks, 1 month, 3 months, 6 months, and thereafter 
every accordingly to patient’s evolution. During follow-up visits, the following data should be 
evaluated: visual acuity, refraction, IOP, number of glaucoma medications, anterior and 
posterior segment evaluation, surgery-related complications, gonioscopic findings and axial 
lengh.11 If a reliable exam and IOP measurement cannot be obtained in clinic, exam under 
anesthesia should be performed.3 
In general, for all glaucoma procedures potential early postoperative complications include: 
hypotony (shallow/flat AC, wound leak, choroidal detachment), hyphema, corneal edema, 
aqueous misdirection, suprachoroidal hemorrhage, vitreous hemorrhage, decompression 
retinopathy, and cystoid macular edema. Potential late postoperative complications included: 
persistent corneal edema, corneal ulcer, dysesthesia, blebitis (if patient had previous 
trabeculectomy), chronic/recurrent iritis, choroidal effusion, cystoid macular edema, hypotony 




III - METHODS  
 
A literature review of articles published from January 1953 (inception) to January 2020 was 
performed using PubMed (MEDLINE) and Cochrane Central Register of Controlled Trials 
(CENTRAL), searching for articles which mention therapeutic results of surgical interventions 
for glaucoma on patients with pediatric glaucoma in an attempt to answer the question “Which 
therapies for pediatric glaucoma have the longest maintained efficacy with least incidence of 
adverse reactions?”. Search keywords included congenital glaucoma, pediatric glaucoma, 
trabeculotomy, iTrack and illuminated microcatheter, were used in this search, with different 
combinations in order to obtain the maximum of available articles. Studies were initially 
screened by the title and abstract and submitted to the full-text assessment if eligible. Then, all 
articles were read with the relevant information being compiled based on therapeutic 
intervention and were critically assessed and interpreted.  
 
A) Types of studies 
There were two types of studies included in this review: eight were case series11,21-23,26-29 and 
three were randomized clinical trials (RCT).7,24,25 
B) Types of participants  
The participants included were pediatric patients (<18 years old) with childhood glaucoma with 
uncontrolled IOP. In most studies, patients with previous glaucoma surgery were excluded 
from analysis,11,24,25,27,28 and in five studies these patients were in the analysis.21-23,26,29  
C) Types of interventions 
The intervention of interest was ab externo 360º trabeculotomy assisted with illuminated 
microcatheter.7,11,22-29 Studies with comparison interventions could be either goniotomy,11 
conventional trabeculotomy,21,23-25,27 or combined trabeculotomy-trabeculectomy.7 
D) Types of outcome measures 
The main clinical outcome in most studies was IOP. The target IOP was different between 
studies: ≤12mmHg (n = 1)25,  ≤15mmHg (n = 1)7 , ≤18 mmHg (n = 3)22-24,  ≤21 mmHg (n=1)21, 
≤21 mmHg and a 30% reduction of IOP (n=4) 11,26,27,29 and ≤22 mmHg and a 30% reduction of 
IOP (n=1).28 
Complete success was considered if target IOP was achieved without any topical medications 
and qualified success if with or without it.  
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IV – RESULTS - COMPARATIVE STUDIES 
 
We included 11 studies in this review (Table 2 details studies characteristics): 
- comparative studies between MAT with goniotomy: 1 11 
- comparative studies between MAT with conventional trabeculotomy: 5 21,23-25,27 
- comparative studies between MAT with trabeculotomy-trabeculectomy: 1 7 
- MAT case series: 4 22,26,28,29 
 
A summarized comparison regarding demographics, glaucoma etiology, type of intervention, 
follow-up, success (complete and qualified) rate, failure causes, IOP, medications and 
complications are detailed in Table 2 and Table 3. 
 
A) Patients Characteristics 
A1) Demographics 
In total 423 patients and 507 eyes were included in these studies, of which 305 eyes (74.9%) 
underwent microcatheter assisted ab externo trabeculotomy (MAT). The average age at the 
time of surgery was 25.7±15.0 months (4m-18y). There was higher male preponderance with 
a mean of 66% (56-91).11,21-29  
A2) Childhood glaucoma type 
Five studies included only patients with primary congenital glaucoma (PCG).7,21,23,25,26 Six 
studies included patients with PCG and/or secondary congenital glaucoma (SCG), which more 
commonly included glaucoma associated with aphakia, aniridia, Axenfeld-Rieger, Sturge-
Weber and Rubinstein-Taybi syndrome.11,22,24,27 One study included patients with PCG, SCG 
and JOAG,29 and another study compared aphakic glaucoma patients in one group and JOAG 
in the other group.28 
A3) Baseline characteristics 
The mean preoperative IOP was 29.6±6.4mmHg (21-36)11,21-29 under a mean number of 
2.0±0.9 (0-4)11,22-24,26-28 glaucoma medications. Average follow up between studies was 





B) Surgical Success 
Success rate wasn’t uniformly reported between studies included in this analysis, from the 11 
ones, 8 performed Kaplan-Meier survival analysis (at different time points)11,21,23,24,26-29 and 
the remaining 3 studies reported success rate at around 12 months of follow-up.7,22,25 Details 
for qualified and complete success are presented in Table 4 and Table 5. 
The average complete success rate was 92.9% (83-100) at 1 month of follow up,23,24,26,27,29 
81.4% (70-91) at 3 months, 23,24,26,27,29 75.0% (62-91) at 6months,23,24,26-29  75.0%  (33-87) at 
12 months11,21-29 and 65.5% (53-80) at 24 months.21,23,24,28 The mean qualified success rate 
was 95.2% (84-100) at 1 month follow up, 23,24,26,27,29  91.1% (90-93) at 3 months,23,24,26,27,29  
89.4% (86-91) at 6months,23,24,26-29 86.8% (44-100) at 12 months,11,21-29 and 83.9% (76-90) at 
24 months.21,23,24,28 The mean survival time for MAT was reported in two studies, with an 
average of 20.1±1.5 months (19-21).23,24   
Regarding the postoperative IOP control and number of glaucoma medications, after MAT 
the average IOP was 13.4±3.7 mmHg (10-19)7,23-25,27,29 with 0.4±0.9 (0-1) medications23,27 at 
6 months, 13.7±3.5mmHg (9-21)7,11,22-27 with 0.4±0.6 (0-1) medications11,22,23,26,27 at 12 
months and 11.5±3.4mmHg (9-13)23,24 with 0.3 ± 0.6 (0-1) at 24 months follow up.23 
In this review in the eyes that underwent MAT, 46 failed, however only in 35 eyes the motif 
for failure was disclosed. In the studies where data was available, 19 eyes (41.3%)22-26,28 failed 
due to need for additional glaucoma surgery, 13 eyes (28.3%)7,21,23,28 due to poor IOP control, 
2 eyes (4.3%) due to endophthalmitis23,24 and 1 eye (2.1%) due to lost to follow-up.28 In the 
group of eyes that failed due to the need for additional glaucoma surgery (n=13), 1 case 
underwent trab-trab25, 3 trabeculectomy,24 1 ciclodestruction28, 3 GDD28 and 5 another type of 
surgery non-specified.23 
 
C) Microcatheter assisted trabeculotomy – successful canalization 
In this analysis of the 305 eyes that underwent MAT, in 197 eyes (64.6%) complete 
canalization of the Schlemm’s canal with illuminated microcatheter was possible and in 108 
eyes (35.4%) only partial canalization was undertaken. In 31 eyes (10.2%) MAT was not 
technically possible, therefore intraoperative conversion to CT was needed. 
The comparative results between studies weren’t homogeneous. Table 6 presents the 
comparison between complete and partial MAT. The analyses demonstrated that partial MAT 
had lesser success rates than complete MAT, with comparative information in this matter only 
in two studies. The first one with CS 82% and QS 82% vs CS 77% and QS 86%, respectively, 
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at both 12 and 36 months follow-up. 21 The second one with CS 50% and QS 67% vs CS 96% 
and QS 100%, respectively, at 12 months follow-up.7  
Six studies did not have information about the success rate between the 2 procedures 11,22-24,28,29 
and the other three had information only about complete25 or partial MAT.26,27 
In two studies IOP reduction was higher with complete MAT vs partial MAT, with 60% vs 
55%, respectively, in the first one29 and 65% vs 52%, respectively, in the last one.11 
No significant difference was achieved in these studies, neither in the success rates 
7,11,21,23,24,26,29, in the postoperative IOP 11,24,26,29 or in the survival times24.  
In one study it was reported a higher need for medication in the partial MAT, p=0.180.7 
 
D) Intraoperative Complications 
Intraoperative complications of MAT were not uniformly reported by all studies. The most 
common complications were hyphema in 92 eyes (30.2%),7,11,23,25 iris prolapse in 2 eyes 
(0.7%),7,25 vitreous hemorrhage in 2 eyes (0.7%)28 and catheter misdirection in 1 eye (0.3%).22 
The only intraoperative complication with conventional trabeculotomy and goniotomy was 
hyphema and occurred in 66 eyes (21.6%) in the first one23,25 and in 13 eyes (4.3%) in the 
second one.11 The only intraoperative complication with trab-trab was iris prolapse in 30 eyes 
(9.8%).7 
 
E) Postoperative Complications 
E.1) Early Complications 
Early postoperative complications with MAT included hyphema in 154 eyes 
(50.5%),11,21,22,24,26,27-29 shallow AC in 6 eyes (2.0%),23,24 vitreous hemorrhage in 2 eyes 
(0.7%),28 transient hypotony with choroidal effusion in 1 eye (0.3%),28 recurrent scleral cyst in 
1 eye (0.3%),28 and localized peripheral Descemet scar in 1 eye (0.3%).28.  
Early postoperative complications with conventional trabeculotomy were hyphema in 23 
eyes (7.3%),24,27 shallow AC in 9 eyes (3.0%),21,23,24 choroidal detachment in 1 eye (0.3%).27 
The only early postoperative complication with goniotomy was hyphema in 13 eyes (4.3%).11 
In trab-trab the most common complications were hyphema in 16 eyes (5.2%)7 and shallow 





E.2) Late Complications 
The only two reported late complications (12 to 24 months of follow-up) associated with MAT 
were cataract in 4 eyes (1.3%)23,24 and late endophthalmitis in 2 eyes (0.7%). 23,24 
With conventional trabeculotomy late complications included cataract in 5 eyes (1.6%),23 
lens subluxation in 2 eyes (0.7%).23 Combined trab-trab presents as late complication one case 
(0.3%) with subcapsular cataract. 
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V – DISCUSSION 
 
This review has included the eleven studies in the current literature that analyzed the efficacy 
and safety of MAT for the treatment of pediatric glaucoma. Some of these studies have 
compared the results of MAT with: goniotomy11, CT21,23-25,27, or Trab-Trab7, and the remaining 
where case series only with MAT.22,26,28,29 These studies are very heterogeneous in concerns 
of study methodology, patient selection, exclusion criteria and study outcomes. This 
heterogeneity precludes a proper statistical comparison.  
From the 11 studies analyzed, 8 were case series11,21-23,2-29, and  3 were RCT.7,24,25 According 
to the pyramid of scientific evidence45, case series have the least validity of all types of clinical 
investigation, this being due to the great bias inherent to their study design, and so, quality of 
evidence tends to be poor. Such biases include selection bias by non-randomizing the sample 
leading to it possibly not being representative of the population, confirmation bias due to the 
same physician evaluating their own surgical results and information bias due to low follow 
up, possible errors in clinical records, no control group and unaccounted confounding factors. 
According to the above, 8 studies showed the typical limitations of retrospective case series, a 
low sample size and a short follow-up and the other 3 studies, as RCT, had the best scientific 
strength.  
Although heterogenous, these studies have common grounds for comparison including: (1) 
most reported success rates were at 12 months of follow-up, (2) the mean preoperative IOP and 
number of medications was also similar between studies, (3) the success criteria were similar 
in most studies, which included achieving an IOP under a target value (1 study target IOP was 
≤22 mmHg,28 4 studies <21 mmHg,11,26,27,29 3 studies ≤18 mmHg22-24, one study ≤15mmHg7 
and another ≤12mmHg25), (4) need for additional surgery as a failure cause, that was reported 
in 6 of the 11 studies23-26, 28 and (5) hyphema was reported as the most common intra and early 
postoperative complication in most studies.7,11,21,22,23,25-27,29 
 
A) Illuminated microcatheter assisted trabeculotomy – Surgical success 
Based on this review of literature, illuminated microcatheter–assisted circumferential 
trabeculotomy presented excellent success rates in most studies. As expected, surgical efficacy 
decreased over time with or without medications. The average complete success rate was 
75.0%  (33-87) at 12 months11,21-29 and 65.5% (53-80) at 24 months21,23,24,28 and the average 
qualified success rate was 86.8% (44-100) at 12 months11,21-29 and 83.9% (76-90) at 24 
months.21,23,24,28 In most cases, good IOP control was achieved with a reduction of the number 
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of glaucoma medications. At 12 months of follow-up the average IOP was 13.7±3.5mmHg (9-
21)7,11, 22-27 with 0.4±0.6 (0-1) medications.11,22,23,26,27 
 
B) Glaucoma type The results achieved by this review seem to suggest that therapeutic 
interventions for SCG are both less successful and more likely to have technical difficulties 
(partial MAT or conversion to CT) in comparison to patients with PCG. At 12 months of 
follow-up, studies that only included PCG patients disclosed a mean CS of 78.9% and QS of 
87.9% and studies that included SCG a CS of 57.8% and a QS of 64.4%.11,21-29 Although the 
group of secondary glaucoma in children is very heterogenous, these results are possibly 
explained by the fact in this group there might be more angle dysgenesis and glaucoma may 
have a more aggressive prognosis.29 
 
C) Previous glaucoma surgery When selecting patients for MAT, medical history also 
warrants attention as patients that underwent previous surgery (non-naïve) have lower success 
rates than naïve eyes. In this review, around 40% of the eyes that underwent MAT had a history 
of previous failed glaucoma surgery11,21-23,26,29 and some of them had more than one procedure. 
Some studies performed a sub analysis comparing success rates between naïve and non- naïve 
eyes.22,23,26,29 At 12 months of follow-up qualified success rate in naïve eyes ranged between 
87.5-100%.22,26,29 On the other hand, non-naïve eyes presented lower success rates, ranging 
from 44.4%-90.1%.11,22,36,29  
Moreover, in the study from Hu et al21 that only included PCG subjects (n=74) with previous 
failed glaucoma surgery, MAT was successfully performed in around two thirds of the cases 
(67.6%), with excellent success rate at 12 (84%) and 36 months (80%). Increased difficulty in 
performing MAT was likely related to SC damage and restriction of catheter passage because 
of the greater number of prior failed glaucoma surgeries. 
Therefore, one can expect that not only cannulation of the SC might be more difficult in eyes 
that have previously undergone glaucoma surgery, but also the rate of success will be slightly 
lower. Although this surgical technique still proved to be an effective option for the 
management of complicated patients who had previously failed surgeries. 
 
D) Complete vs Partial MAT The debate regarding the minimum degree of angle opening 
required for successful IOP reduction in pediatric glaucoma patients is controversial. In this 
review, some studies performed a sub analysis comparting the results between eyes with 
complete (>250º) and partial (180-250º) MAT.11,21-29 Seven studies found no statistically 
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difference in success rates between complete and partial MAT. 7,11,21,23,24,26,29 Nevertheless, 
there was a tendency for lower success rates in the eyes with partial MAT 7,21 and a higher need 
for medication.7 Furthermore, there was higher IOP reduction with complete MAT.11,29 
However, no significant difference was achieved in the postoperative IOP 11,24,26,29 or in the 
survival times24.  
A major advantage of MAT, even when done partially, is that the illuminated tip facilitates the 
placement and advancement of the microcatheter. This allows for more accurate placement of 
the catheter for a precise opening of the inner wall of SC. It has been reported that aqueous 
humor outflow is segmental and that only two aqueous veins could account for all of aqueous 
outflow in normal human eye at any given time. Therefore, it makes sense that partial opening 
of Schlemm’s canal may be sufficient to lower IOP so long as it is performed accurately.  
 
E) Complications and Failure From this review hyphema was shown to be the most common 
intra (30.2%, n=92) and postoperative (40.5%, n=154) complication following MAT. This 
might be related to the greater extent of tissue disturbance with circumferential treatment, in 
comparison to conventional angle procedures which usually only treat 180º. On the other hand, 
as a greater extent of the angle is incised, one would might expect that the rate of shallow AC 
and choroidal detachment would be greater with this technique, however this was not observed. 
The rate of shallow AC with MAT was 2.0%, which was similar to the rate in CT (3.0%), and 
both were higher in comparison to goniotomy (0.7%). Moreover, choroidal detachment was 
rarely seen occurring only in 0.3% of the cases in MAT and CT, and it was not reported with 
goniotomy. When using the illuminated microcatheter, intraoperatively catheter misdirection 
occurred only in 1 eye (0.3%)22 and there were no cases reported of Descemet trauma, irido or 
cyclodyalisis. Although, these studies did not report the rate of these complications when using 
the trabeculotome, from previous studies, rigid probe misdirection is known to be a major 
problem.46 In the last years, several attempts have been made to minimize this problem 
including the use of prolene suture and now the illuminated microcatheter.46  
There were also few late complications, after 12 to 24 months of follow-up, including cataract 
which occurred in 1.3%23,24 and endophthalmitis in 0.7%,23,24 with similar rates reported for 
CT (cataract 1.6% and endophthalmitis 0.7%).23 Based on these results MAT seems to be a 
safe procedure with few sight threatening complications.  
Regarding the causes for failure in eyes that underwent MAR, the 2 most common were the 
need for additional glaucoma surgery (41.3%)22-26,28 and poor IOP control (28.3%).7,21,23,28 In 
a minority (4.3%) failure was due to endophthalmitis23,24 and there were no cases of failure due 
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to loss of light perception. These results also support that trabeculotomy assisted my 
illuminated microcatheter discloses a good safety profile as a recent surgical procedure. 
 
F) Comparison between MAT and other Pediatric Glaucoma Surgeries  
 
F1) MAT vs CT There were four studies that compared the efficacy of 360º MAT over CT, 
three of these performed the classic 180º CT, 24,25,27 and one a two site 360º CT.23 The results 
of the studies that compared MAT with 180º CT, confirmed the superiority of MAT  in terms 
of higher IOP reduction as well as higher success rates.24,25,27 Although patient selection was 
different between studies, as Shakrawal et al.25 and El Sayed et al.24 only included PCG 
patients, however Shi et al.27 included different childhood glaucoma types ( but mostly PCG). 
Additionally, these three studies excluded patients with previous glaucoma surgery, which 
allows a better comparison between results. Overall, at 12 months of follow-up the qualified 
success rate of MAT varied between 86.4%27 and 90%25, and at 24 months was 85.2% in El 
Sayed et al.24 study. On the other hand, during the same follow-up period, CT qualified success 
rate in these studies ranged between 50-70%.24,25,27 
The study by El Sayed et al.23 disclosed different results, as two-site CT had a higher qualified 
success rate at final follow-up (mean 20months), CT 86.2% vs MAT 75.8%. 
These results confirm that the microcatheter approach offers the advantage of in one passage 
incising the SC 360º, which has a higher success rate compared to 180º CT. 24,25,27 Additionally, 
with MAT as the microcatheter passes circumferentially over 360◦ and reappears from the 
opposite end of SC one can be sure that the whole canal was incised. Whereas CT is a relatively 
more blind procedure, and although it is preferred to deroof the SC underneath the scleral flap 
to make sure that the probe enters in the correct plane, one cannot guarantee that the probe will 
not become misdirected when it proceeds further circumferentially. 
In comparison to the 2 site CT23 the microcatheter technique failed to achieve superiority, 
nevertheless it presents one advantage being that only one scleral wound is performed hence 
allowing for a smaller area of conjunctival dissection. These authors state that, both techniques 
may be recommended as a first line procedure in pediatric eyes requiring trabeculotomy, 
however the added cost of the microcatheter could be an unnecessary financial burden in many 
places where pediatric glaucoma is common. Nevertheless, 2 site CT is a technique that most 
surgeons are not used to perform, as there is more experience with the classic 180º CT.32,46 
Moreover, the study by Hu et al.21 included PCG patients after previous failed glaucoma 
surgeries and analyzed the efficacy of MAT. One group included eyes with successful MAT 
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(n=50) and the other group included eyes that intraoperatively MAT was not technically 
possible, and therefore converted to CT (n=24). After 12 months of follow up qualified success 
rate in MAT group was 80% and in the CT group was 55.8%. At 36 months MAT success rate 
maintained the same, however CT decreased to 37.0%. In this study, although MAT disclosed 
a higher success rate, it highlighted that in some cases where the passage of the illuminated 
microcatheter was interrupted by an obstruction and a completion of the trabeculotomy was 
attempted by the trabeculotome, the rigid probe managed to pass through the obstruction. It is 
likely that the flexibility and smaller diameter of the microcatheter makes it less resistant to 
obstructions in SC and more prone to become misdirected into the narrow collector channels.  
 
F2) MAT vs Goniotomy Only one study compared the success rate of MAT with goniotomy 
in congenital glaucoma patients (most were PCG) and previous glaucoma surgery was not an 
exclusion criteria.11  Similarly to the studies that compared MAT with CT, this study revealed 
that MAT had a statistically significant higher rate of success than goniotomy for CS (p=0.06) 
and QS (p=0.04). At 12 months of follow-up, qualified success with MAT was 91.6% 
exceeding the success rate of conventional goniotomy (QS 53.8%). The authors stressed that a 
possible significant bias between the two groups in this study was that more eyes in the MAT 
group had undergone previous surgery, which can lead to worse results in this group. As with 
CT, goniotomy only treats 180º in each surgery, which in comparison to 360º MAT might be 
responsible for the lower success rate of this technique. Furthermore, goniotomy demands a 
relatively transparent cornea, whereas MAT can be performed even in patients with severe 
corneal edema. Although, goniotomy has the advantage of being an ab interno procedure, 
therefore leaving the conjunctiva untouched, which in the future does not compromise the 
success rate of other glaucoma procedures which depend on the conjunctiva status.32 
 
F3) MAT vs Trab-Trab In this review, we found one study that compared the success rate of 
MAT with combined Trab-Trab with MMC in PCG patients that had no previous history of 
glaucoma surgery.7 The results were similar after 12 months of follow-up, CS was 86.7% and 
QS was 93.3% on the MAT group against a CS of 90.0% and QS of 93.3% on the Trab-Trab 
group. As the combined procedure is associated with a high rate of long-term complications, 
due to the presence of a bleb and the use of MMC, the authors suggest that MAT could be 
resorted to first, saving Trab-Trab for future intervention. However, the cost associated with 
the disposable illuminated microcatheter, steeper learning curve in comparison to conventional 
surgeries, and a higher incidence of hyphema were some of the disadvantages pointed out for 
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the illuminated microcatheter trabeculotomy, factors that may hold special relevance in 
developing nations. 
 
Finally, another main advantage of MAT worth noting is the ability to treat the entire angle in 
one surgery, which minimize anesthetic risks. Retrospective studies in humans have shown a 
higher prevalence of learning disabilities in children who received multiple exposures to 
general anesthesia before the age of 4 years. Animal studies suggest an association between 
general anesthesia and neurodevelopmental delay.  Therefore, the relative lifelong risks and 
complications of general anesthetic exposure should be considered when recommending 





VI - CONCLUSIONS 
 
Pediatric glaucoma surgery is challenging in many aspects, from appropriate surgical planning 
and intraoperative technique to postoperative management. For PCG patients who present 
before 1 year of age, goniotomy and trabeculotomy have good success rates. However, in 
patients with pediatric glaucoma with a poor prognosis, such as aphakic glaucoma or secondary 
glaucoma associated with ocular or systemic anomalies, the success rates are lower. 
Furthermore, approximately 20% of angle surgeries fail over time and a second procedure will 
be required. CT seems to be more effective than either procedure alone in more severe cases 
of congenital glaucoma. Filtration surgery, in the form of trabeculectomy or combined Trab-
trab and GDD surgery, may be necessary when maximal medical therapy fails.  
This literature review showed that illuminated microcatheter assisted circumferential 
trabeculotomy can be successfully used to catheterize Schlemm’s canal and perform partial 
and full circumferential trabeculotomy for the treatment of pediatric glaucoma. It seems to 
provide excellent pressure-lowering effect with minimal complications in the early 
postoperative course (up to 24 months). Even in patients with previous surgeries, the effect was 
comparable to that in eyes that underwent this procedure as an initial intervention. 
Based on this analysis, illuminated microcatheter–assisted trabeculotomy offers few 
advantages over other conventional surgeries. There is minimal risk of false passage creation 
with guided endo-illuminator passage, unlike the Harms or suture trabeculotomy. Moreover, 
the incidence of adverse effects associated with full thickness trabeculectomy, such as shallow 
anterior chamber, cataract formation, infections, late hypotony, and suprachoroidal 
hemorrhage were lower with MAT. Also, postoperative inflammation could be lesser with 
MAT owing to the minimal iris manipulation required. However, the cost associated with the 
disposable illuminated microcatheter and steeper learning curve in comparison to conventional 
surgeries are some of the disadvantages of illuminated microcatheter trabeculotomy that may 
hold special relevance in developing nations and could be an unnecessary financial burden in 
many places where pediatric glaucoma is common. 
In the future, further research is warranted to determine the long-term success and safety of 
this procedure.  
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IX – ANNEXES 
 
IX.I – FIGURES 
 
 
Figure 1. Diagnostic criteria and Classification system for pediatric glaucoma. Adapted from New 
classification system for pediatric glaucoma: implications for clinical care and a research registry. 30 
 
 
Figure 2. Exposure of Schlemm’s canal (arrow). Adapted from Canaloplasty for Adult OAG Interim 
Clinical Study Analysis 12  
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A B 
Figure 3. Ab externo Trabeculotomy assisted with illuminated microcatheter. A - 
Catheterization of Schlemm’s canal with beacon tip visible through sclera (arrow). B - 
Trabecular tensioning sutures (arrow) in Schlemm’s canal. Two suture loops are in place. 
Adapted from Canaloplasty: Circumferential viscodilation and tensioning of Schlemm’s canal using a flexible 
microcatheter for the treatment of open-angle glaucoma in adults. 12 
Figure 4. The UBM images of the anterior angle before (left) and after (right) canaloplasty 
showing dilation of Schlemm’s canal. The tensioning suture is noted by the arrow. Adapted from 
Canaloplasty: Circumferential viscodilation and tensioning of Schlemm’s canal using a flexible microcatheter 
for the treatment of open-angle glaucoma in adults.12 
Figure 5. The UBM images of exemplary trabecular meshwork dis- tension grades. Arrows 
indicate the location of tissue distension. Adapted from Canaloplasty: Circumferential viscodilation and 
tensioning of Schlemm’s canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults.12 
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Figure 6. The iTrack microcatheter used has a 200μm diameter shaft with a blunt distal tip of 
about 250 μm in diameter. Adapted from Canaloplasty: Circumferential viscodilation and tensioning of 
Schlemm’s canal using a flexible microcatheter for the treatment of open-angle glaucoma in adults.12 
 







Figure 7. Gonioscopy-assisted ab-interno 360º 
trabeculotomy procedure with suture. A - Initial 
cannulation of Schlemm’s canal (SC) within the AC. B - 
The catheter (or suture) is passed 360º around the canal. C 
- The distal tip of the catheter (or suture) is retrieved and 
externalized, creating circumferential trabeculotomy.  
(1) SC; (2) Initial goniotomy site; (3) Microsurgical 
forceps; (4) Either the suture or microcatheter; (5) Distal 
end of the suture or microcatheter after it passing 360º 
around SC; (6) Path of the suture or microcatheter within 
SC; (7) Trabecular shelf that is created after this 
procedure; (8) Trabeculotomy that is created when the 
distal end of the suture or catheter is retrieved and 
externalized.  
Adapted from Gonioscopy-Assisted Transluminal Trabeculotomy, Ab 
Interno Trabeculotomy Technique Report and Preliminary Results 14 
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Figure 9. Deep sclerectomy performed in a child with glaucoma secondary to Sturge-Weber 
Syndrome. Adapted from Current Surgical Options for the Management of Pediatric Glaucoma 6 
 
  
Figure 8. Gonioscopy-assisted ab interno trabeculotomy 
with illuminated microcatheter. (A) Initially a goniotomy 
is created with an MVR blade. (B) Schlemm’s canal (SC) 
is then cannulated with a microcatheter, using 
microsurgical forceps.  (C) The catheter was passed 2–3 
clock hours around SC. (D) The catheter has passed 180° 
around the canal. (E) The microcatheter has come full 
circle around the canal. (F) The distal tip of the catheter is 
retrieved within the AC using microsurgical forceps.  
Adapted from Gonioscopy assisted transluminal trabeculotomy: An 
ab interno circumferential trabeculotomy for the treatment of primary 
congenital glaucoma and juvenile open angle glaucoma. 3 
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IX.II – TABLES 
 
Table 1. Comparison of Angle Surgery Techniques for Pediatric Glaucoma. Adapted from 







Surgical groups Inclusion criteria Exclusion criteria Success rate Failure causes 
Hu et al.21 
China 
 2019 
Aim: Evaluate effectiveness 
of MAT to treat PCG after 
failed previous glaucoma 
surgeries. 
Success criteria*: Final IOP 
≤21 mmHg with (QS) or 
without (CS) medications. 
Group 1: MAT – 50 eyes. 
Complete MAT (≥330º) - 
22 eyes. 
Partial MAT (180º-330º) - 
28 eyes. 
Group 2: Cases converted to 
CT, when SC couldn’t be 
catheterized >180º - 24 eyes. 
• The previous failed 
glaucoma surgeries (≥1 CT or 
filtering surgery). 
• Diagnosis of PCG: (1) 
isolated trabeculodysgenesis 
(2) No other ocular/ systemic 
abnormality. (3) Elevated IOP, 
increased corneal diameter, 
corneal edema, increased axial 
length, and glaucomatous optic 
nerve cupping. 
• Previous ophthalmic 
surgery other than 
glaucoma surgery; 
 
• > 180º of PAS. 
Group 1: QS 84.0%, and CS 80.0% at both 
12 and 36 months postoperative. 
Complete MAT:  QS and CS 86.4% at 
12 months; QS and CS 77.3% at 36 
months post-operative. 
Partial MAT:  QS and CS 82.2% at 12 
and 36 months post-operative. 
Group 2:  QS 55.8%, and CS 33.3% at 12 
months and QS 37.0% and CS 29.2% at 36 
months post-operative. 
Group 1: 4 eyes – 
uncontrolled IOP. 
Eyes with failure had 
a significantly higher 
number of previous 
surgeries  
p<0.001 
Group 2: No info. 
Toschev et al.22 
Germany 
2018 
Aim: Determine feasibility, 
efficacy, and safety of MAT 
for congenital glaucoma. 
Success criteria*: Final IOP 
≤18 mm Hg with (QS) or 
without (CS) medications. 
Group 1: PCG naïve (**)– 23 
eyes. 
Group 2: PCG non-naïve (**) 
- 3 eyes; SCG - 10 eyes (4 of 
them non-naïve). 
• Childhood glaucoma; 
• Non-naïve eyes were not 
excluded. 
No info. 
Group 1: CS 80.0%, QS 100.0%, at 14 
months. 
Group 2: CS 33.3%, QS 44.4% at 8 months. 
* 
Group 1: no failures. 
Group 2: 5 eyes 
failed – SC occlusion 
or high tissue 
resistance of TM, all 
converted to CT. 
El Sayed et al.23 
Egypt  
2018 
Aim: Compare the outcomes 
of MAT with 2 site CT 
(360º) in PCG patients. 
Success criteria*: Final IOP 
≤18 mm Hg with (QS) or 
without (CS) medications. 
Group 1: MAT – 33 eyes. 
Previous goniotomy 18.2%. 
Group 2: CT – 59 eyes. 
Previous goniotomy 16.9%. 
• PCG; 
• Age < 12 years-old; 
• ≥ 6 months follow-up; 
• Eyes with previous 
goniotomy were not 
excluded. 
• Combined procedures; 
• Previous CT; 
• CT ≤ 270°; 
• MAT <180°. 
At final follow-up (mean 19.7 months): 
Group 1: MAT 72.7% CS and 75.8% QS; 
58% complete 360◦ incision; 
Group 2: CT 81.0% CS and 86.2% QS; 
56% had complete 360º incision; 
Mean survival time MAT - 20.9±1.3 months 
and CT 21.4±0.92 months. 
No significant 
difference in failure 
rates between groups 
p=0.200 
Group 1: 8 eyes– 5 
need another 
glaucoma surgery, 2 
elevated IOP and 1 
late post-operative 
endophthalmitis. 
Group 2: 8 eyes – 7 
need another 
glaucoma surgery and 
1 uncontrolled IOP. 
El Sayed et al.24 Egypt 
 2017 
Aim: Compare the outcomes 
of MAT to CT in childhood 
glaucomas. 
Success criteria*: Final IOP 
≤18 mm Hg with (QS) or 
without (CS) medications. 
Group 1: MAT – 30 eyes 
Complete (360º) - 50% 
Partial (250-250º) - 50% 
Group 2: CT – 32 eyes 
• PCG; 
• Age < 10 years old; 
• ≥6 months follow-up; 
• In bilateral cases, only 1 eye 
was included (higher IOP). 
• Previous surgery; 
• Combined procedures; 
• Trabeculotomy 
involved ≤120° SC. 
 
At 2 years of follow-up: 
Group 1: MAT – CS 66.7% and QS 85.2% 
3 lost of follow-up. 
Group 2: CT – CS 46.7% and QS 50.0% 
2 lost of follow-up. 
The mean survival time was significantly 
longer (p=0.01) for MAT (19.3±1.6 months) 
compared to CT (12.4±1.8 months). 
Group 1: 4 eyes– 3 
need for another 
glaucoma surgery; 1 
late endophthalmitis. 
Group 2: 16 eyes– 
13 need for additional 
glaucoma surgery and 








Aim: Compare 1-year 
outcomes of MAT vs CT in 
PCG. 
Success criteria*: Final IOP 
≤12mmHg with (QS) or 
without (CS) medications. 
Group 1: MAT – 20 eyes 
Complete 80%. 
Group 2: CT – 20 eyes. 
• PCG unilateral or bilateral; 
• Age <2 years old. 
• Secondary glaucoma; 
• Previous eye surgery; 
• Parents not willing for 
consent and follow-up. 
At 12 months of follow-up: 
Group 1: CS 80%, QS 90%; 
Complete MAT: CS 87.5%; QS 93.8%; 
Group 2: CS 60%, QS 70%. 
Differences in success rates (CS and QS) 
between groups were statistically significant 
(p< 0.001). 
Group 1: 4 eyes – 1 
need for additional 
glaucoma surgery and 
3 no motif was 
reported. 
Group 2: 6 eyes – 4 
need for additional 
glaucoma surgery and 
2 no motif was 
reported. 
Shi et al.26 
China 
 2017 
Aim: Compare surgical 
outcomes of MAT following 
failed angle surgeries with 
the ones with no previous 
angle surgery, in PCG. 
Success criteria*: Final IOP 
≤21 mmHg and 30% 
reduction with (QS) or 
without (CS) medications. 
Group 1: Patients without 
previous angle surgeries – 20 
eyes. 
Group 2: Patients who 
underwent ≤ 2 previous failed 
angle surgeries (goniotomy, 
trabeculotomy, trab-trab) – 22 
eyes. 
• Diagnosis of PCG: (1) 
isolated trabeculodysgenesis 
(2) No other ocular/ systemic 
abnormality. (3) Elevated IOP, 
increased corneal diameter, 
corneal edema, increased axial 
length, and glaucomatous optic 
nerve cupping. 
 
• Previous > 2 angle 
surgeries; 
• Previous ophthalmic 
surgery besides angle 
surgeries; 
• >180° of PAS. 
At 12-month follow-up: 
Group 1: CS 78.9%, QS 90.0%; 
Group 2: CS and QS 77.3%. 
No statistical significant difference between 
groups (CS p=0.85; QS p=0.29). 
Group 1: 2 eyes, no 
motives reported. 
Group 2: 2 eyes – 1 
need for additional 
glaucoma surgery and 
1 no motif reported. 
 
Shi et al.27 
China 
 2016 
Aim:  Compare the 
outcomes of MAT to CT in 
childhood glaucomas. 
Success criteria*: Final IOP 
≤ 21 mm Hg and 30% 
reduction with (QS) or 
without (CS) medications. 
 
Group 1: MAT – 22 eyes. 
Group 2: CT – 21 eyes. 
• Diagnosis of childhood 
glaucoma including elevated 
IOP, increased corneal 
diameter, corneal edema, 
increased axial length and 
glaucomatous cupping of 
the optic nerve; 
• Examination under 
anesthesia with 80MHz 
UBM to access suitability 
for trabeculotomy. 
• Previous surgery; 
• >180° of PAS. 
 
At 12-month follow-up: 
Group 1: CS 81.0% and QS 86.4%. 
Partial MAT: (n=3) all eyes were 
successful at 12-month follow-up. 
Group 2: CS 51.6% and QS 61.9%. 
No statistical significant difference between 
groups for QS (p=0.06), however for CS 
significance was found (p=0.04). 
Group 1: 3 eyes, no 
motives reported. 
Group 2: 9 eyes – 4 
need for additional 
glaucoma surgery and 
5 no motives 
reported. 
 
Temkar et al.7 India 
2015 
Aim: To compare outcomes 
of MAT vs combined Trab-
Trab with MMC for PCG. 
Success criteria*: Final IOP 
≤15mmHg with (QS) or 
without (CS) medications. 
 
Group 1: MAT – 30 eyes. 
Group 2: Trab-Trab MMC – 
30 eyes. 
 
• Bilateral PCG; 
• age < 2 years-old; 
• Examination under 
anesthesia to confirm the 
disease and its baseline 
severity. 
• Unilateral disease; 
• secondary glaucoma; 
• previous ocular 
surgery; 
• parents not willing for 
consent and follow-up. 
At 12 months of follow-up: 
Groups 1: CS 86.7%; QS 93.3%; 
Group 2: CS 90.0%; QS 93.3%. 
No statistical significant difference between 
groups for QS (p=1.00) or CS (p>0.99). 
Group 1: 2 eyes, 
uncontrolled IOP. 




Table 2. Ten studies comparison with illuminated microcatheter assisted trabeculotomy – Study’s aims, success criteria, inclusion and exclusion criteria, success 
rate and failures.  
Abbreviations: AC: anterior chamber; CS: complete success; CT: Conventional Trabeculotomy; IOL- intraocular lens; IOP: intraocular pressure; JOAG: juvenile open angle glaucoma; MAT- 
microcatheter assisted trabeculotomy; MMC- mitomycin C; QS: qualified success;  PAS: peripheral anterior synechiae; PCG: primary congenital glaucoma; SC-schlemm’s canal; TM: trabecular 
meshwork; Trab-Trab: trabeculotomy-trabeculectomy; UBM: ultrasound biomicroscopy. 
 (*) failure was considered if no such pressure could be achieved despite maximum tolerated medical treatment, or if a subsequent glaucoma procedure was needed to control the IOP or if a 
devastating complication occurred (e.g. retinal detachment, endophthalmitis or supra-choroidal haemorrhage). (**) naïve eyes are eyes considered naïve to glaucoma surgeries and non-naïve 
eyes are eyes that already underwent previous glaucoma surgeries.  
 
Dao et al.28 
USA 
2014 
Aim:  To determine the 
safety and efficacy of MAT 
for refractory aphakic 
glaucoma and JOAG. 
Success criteria*: Final IOP 
≤22mmHg and > 30% 
reduction, and glaucoma 
stability with or without 
medications. 
Group 1: Aphakic glaucoma – 
13 eyes; 
Group 2: JOAG – 10 eyes. 
• ≥6 months follow-up; 
• JOAG < 30 years at time of 
diagnosis; 
• In bilateral cases, only the 
1st operated eye was 
included. 
• Anterior segment 
anomalies; 
• Extensive PAS; 
• Congenital glaucoma; 
• Previous/planned ocular 
surgery (other than 
secondary IOL). 
At 24-month follow-up: 
Group 1: CS 0.0% and QS 61.5%; 
Group 2: CS 20.0% and QS 90.0%. 
Group 1: 5 eyes – 3 
need of additional 
surgery, 1 
uncontrolled IOP; 1 
lost of follow-up. 
Group 2: 1 eye, need 
of additional surgery. 
Girkin et al.29 USA  
2012 
Aim: To determine the 
safety and efficacy of MAT 
for congenital glaucoma. 
Success criteria*: Final IOP 
<21 mmHg and > 30% 
reduction with (QS) or 
without (CS) medications. 
Total: 11 eyes. 
 
• Diagnosis of childhood 
glaucoma including elevated 
IOP, increased corneal 
diameter, corneal edema, 
increased axial length and 
glaucomatous cupping of 
the optic nerve; 
• ≥6 months follow-up 
• Eyes with previous angle 
surgery were not excluded. 
No info. 
At 12 months of follow-up: 
• CS 81.8% and QS 90.1%; 
 
• If eyes with previous angle surgery were 
excluded, CS 87.5% and QS 100%. 
1 eye, no motif 
reported. 
Girkin et al.11 
USA 
2012 
Aim: To compare MAT with 
goniotomy for congenital 
glaucoma. 
Success criteria*: Final IOP 
<21 mmHg and > 30% 
reduction with (QS) or 
without (CS) medications. 
Group 1: MAT – 11 eyes; 
6 eyes 360º, 3eyes 370º, 2eyes 
180º. 
Group 2: Goniotomy – 13 
eyes. 
• Diagnosis of childhood 
glaucoma including elevated 
IOP, increased corneal 
diameter, corneal edema, 
increased axial length and 
glaucomatous cupping of 
the optic nerve. 
No info. 
At 12 months follow-up: 
Group 1: MAT – QS 91.6% and CS 83.3%; 
Group 2: Goniotomy QS 53.8% and CS 
46.2%. 
Difference between groups was statistically 
significance. The survival curves show that 
MAT had a higher rate of success than 
goniotomy for CS (p=0.06) and QS 
(p=0.04). 
Group 1: 1 eye, no 
motif reported. 
Group 2: 6 eyes, no 
motif reported. 
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Title 
Mean IOP (range), mmHg Mean number of glaucoma medications (range) Surgical Complications 







Hu et al.21 
Group 1 - 
35.3±7.0 
Group 2 - 
33.1±6.3 
No info. No info. 
At 3 years 
Group 1 - 
17.7±8.6 
p<0.001** 
Group 2 - 
25.8±10.0 
p=0.004** 
Group 1 - 
2.7±0.8 
Group 2 - 
3.0±0.7 
 
No info. No info. 
At 3 years 
Group 1 - 0.6±1.2, 
p<0.001** 
Group 2 - 2.0±1.4, 
p=0.002** 
Hyphema (n not 
reported). 
Group 1 – 1 eye 
transient hyphema. 
Group 2 - 1 eye 
transient shallow AC. 
No info. 
Toschev et al.22 
Group 1 - 
28.6±5 
Group 2 - 
29.6±9 
No info. 
Group 1 - 
13±2.7 
Group 2 - 
20.2±7.1 
No info. 
Group 1 - 0.8 
Group 2 - 1.8 
No info. 
Group 1 - 0.3 
Group 2 - 0.9 
No info. 




All eyes had mild 
hyphema. No info. 
El Sayed et al.23 
Group 1 - 
24.0±5.9 (12-
38) 












Group 1 - 
12.6±4.1 
(7-24) 




At 3 years: 
Group 1 - 13.3 ± 
5.0 (6-28) 




Group 1 - 0.8 
± 1.0 (0-3) 
Group 2 -1.5 ± 
0.8 (0-3) 
p<0.050* 
Group 1 - 
0.3±0.7 (0-
2) 




Group 1 - 
0.3±0.7 (0-2) 




At 3 years: 
Group 1 - 0.5±0.9 
(0-3) 
Group 2 - 0.3±0.7 
(0-3) 
p=0.310* 
All eyes hyphema. 
 
Group 1 - 3 eyes 
transient shallow AC. 
Group 2 - 7 eyes 
transient shallow AC. 
 
Group 1 - 1 eye 
endophthalmitis at 
13 m and 3 eyes 
cataract. 
Group 2 - 5 eyes 
cataract and 2 eyes 
lens subluxation 
(90-180º). 
El Sayed et al.24 
Group 1 - 
25.1±6.4 (12-
38) 













Group 1 - 
11.9±3.4 
(7-24) 




At 2 years: 
Group 1 - 
11.4±2.5 (8-16) 
Group 2 - 12 
.6±4.4 (8-24) 
p=0.400* 





Group 1 - 
0.5±0.8 (0-
2) 
Group 2 - 
0.7±0.9 (0-
3) 
p = 0.400* 
Group 1 - 
0.2±0.6 (0-2) 
Group 2 - 
0.4±0.8 (0-2) 
p=0.500* 
At 2 years: 
Group 1 - 0.2±0.5 
(0-2) 




Group 1 - 3 eyes 
transient shallow AC; 
and 2 eyes transient 
hyphema. 
Group 2 - 1 eye 
transient shallow AC 
and 2 transient eyes 
hyphema. 
Group 1 - 1 eye 
endophthalmitis 
and 1 eye cataract. 
Group 2 - none. 
Shakrawal et 
al.25 
Group 1 - 
24.7±3.9 











Group 1 - 
9.5±2.4 
Group 2 - 
11.7±2.1 
p<0.000* 
No info. No info. No info. No info. No info. 
Group 1 - 1 eye 
iris prolapse and 18 
eyes hyphema. 
Group 2 - 7 eyes 
hyphema. 
None. No info. 
Shi et al.26 
Group 1 - 
31.5±7.2 





Group 1 - 
15.6±3.1 




Group 1 - 3 
(0-5) 




Group 1 - 0 
(0-4) 
Group 2 - 0 
(0-2) 
p<0.000* 
No info. Hyphema (n not reported). 





Table 3.  Data regarding pre and postoperative: IOP, number of medications and surgical complications during follow-up time – ten studies comparison with 
illuminated microcatheter assisted trabeculotomy. *comparison between groups **comparison between preoperative and postoperative. ***IOP postoperative at 
6 and 12 months. 
Abbreviations: AC: anterior chamber; CT: conventional trabeculotomy; IOP: intraocular pressure; M: month; n: number. 
Shi et al.27 
Group 1 - 
33.1±6.1 











Group 1 - 
14.8±2.5 




Group 1 - 3 
(1–5) 
Group 2 - 2 
(1–4) 
p= 0.001* 
Group 1 - 
0.5 ± 1.1 
Group 2 - 
1.3 ± 1.5 
p=0.020* 
Group 1 - 
0.1±0.3 (0-1) 




Hyphema (n not 
reported). 
 
Group 1 - All eyes 
transient hyphema. 




Temkar et al.7 
Group 1 - 
21.8±9.8 











Group 1 - 
11.6±3.3 
Group 2 - 
11.6±3.0 
p=0.960* 
No info. No info. No info. No info. No info. 
Group 1 - 1 eye 
iris prolapse, 30 
eyes hyphema (2 
total hyphema). 
Group 2 - All eyes 
iris prolapse. 
Group 1 – 29 eyes 
transient hyphema; 1 
hyphema needed 
drainage. 
Group 2 - 16 eyes 
transient hyphema; 2 
eyes transient 
shallow AC. 
Group 2 - 1 eye 
subcapsular 
cataract. 
Dao et al.28 
Group 1 - 
35.4±4.7 
Group 2 - 
30.4±7.1 
No info. No info. 
At 47 m follow-
up: 
Group 1 - 
21.9±8.6 
p=0.0004** 




Group 1 - 2.5 
(2-4) 
Group 2 - 3.5 
 
 
No info. No info. 
At 47 m follow-
up: 
Group 1 - 1.9 
p=0.070** 
Group 2 - 2.2 
p=0.030** 
Group 1 - 2 eyes 
vitreous 
haemorrhage. 
Group 1 - Transient 
hyphema common (n 
not reported); 
1 eye transient 
choroidal effusion; 
1 eye recurrent 
scleral cyst; 
1 eye Descemet scar; 
2 eyes vitreous 
haemorrhage (both 
requiring PPV). 
Group 2 - 2 eyes 
transient hyphema. 
No info. 




No info. No info. No info. No info. No info. No info. No info. All eyes transient hyphema. No info. 
Girkin et al.11 
Group 1 - 35.7 
Group 2 - 36.3 
p=0.877* 
No info. No info. 
Group 1 - 
17.1±3.5 
Group 2 - 
25.3±11.9 
p=0.031 * 
Group 1 - 
1.6±0.6. 
Group 2 - 
1.6±0.7 
No info. No info. 
Group 1 - 0.4±0.9 
 
Group 2 – 1.1±1.1 







Study Hu et al.21 El Sayed et al.23 El Sayed et al.24 Shi et al.26 Shi et al.27 Dao et al.28 Girkin et al.29 Girkin et al.11 
Patients, 
number 22 28 33 30 20 22 22 13 10 11 11 
Study 
design 
PCG after failed surgery PCG 
MAT vs CT 
Childhood glaucoma 
MAT vs CT 
MAT in PCG after failed surgery Childhood 
glaucoma 










MAT vs goniotomy Complete MAT 
≥330º 
Partial MAT 
<330º No previous ≤ 2 previous 
M1 - - 100.0% 83.3% 85.0% 86.4% 95.5% - - 100.0% 100.0% 
M3 - - 72.7% 70.0% 85.0% 81.8% 90.9% - - 90.1% 100.0% 
M6 - - 69.7% 64.3% 85.0% 77.3% 90.9% - - 81.8% 83.3% 
M12 86.4% 82.2% 72.7% 70.3% 78.9% 77.3% 81.0% - - 81.8% 83.3% 
M24 - - 72.7% 66.6% - - - 0.0% 20.0% - - 
M36 86.4% 82.2% - - - - - - - - - 
Table 4. Comparison between cumulative probability of complete success for microcatheter assisted trabeculotomy. Abbreviations: CT: conventional 
trabeculotomy; JOAG: juvenile open angle glaucoma; M: month; MAT: microcatheter assisted trabeculotomy; PCG: primary congenital glaucoma. 
Abbreviations: CT: conventional trabeculotomy; JOAG: juvenile open angle glaucoma; M: month; MAT: microcatheter assisted trabeculotomy; PCG: primary congenital glaucoma. 
 
Study Hu et al.21 El Sayed et al.23 El Sayed et al.24 Shi et al.26 Shi et al.27 Dao et al.28 Girkin et al.29 Girkin et al.11 
Patients, 
number 22 28 33 30 20 22 22 13 10 11 11 
Study 
design 
PCG after failed surgery PCG 
MAT vs CT 
Childhood glaucoma 
MAT vs CT 
MAT in PCG after failed surgery Childhood 
glaucoma 





MAT vs goniotomy complete MAT ≥330º 
partial MAT 
<330º No previous ≤ 2 previous Aphakic JOAG 
M1 - - 100.0% 93.3% 90.0% 84.2 95.5% 76.9% 90.0% 100.0% 100-0% 
M3 - - 90.9% 93.3% 90.0% 90.9 90.9% 69.2% 90.0% 90.1% 100.0% 
M6 - - 87.9% 89.9% 90.0% 86.4 90.9% 61.5% 90.0% 90.1% 100.0% 
M12 77.3% 82.2% 87.9% 89.9% 90.0% 77.3 86.4% 61.5% 90.0% 90.1% 91.6% 
M24   75.8% 85.2% - - - 61.5% 90.0% - - 
M36 77.3% 82.2% - - - - - - - - - 
Table 5. Comparison between cumulative probability of qualified success rate for microcatheter assisted trabeculotomy. Abbreviations: CT: conventional 
trabeculotomy; JOAG: juvenile open angle glaucoma; M: month; MAT: microcatheter assisted trabeculotomy; PCG: primary congenital glaucoma. 
Abbreviations: CT: conventional trabeculotomy; JOAG: juvenile open angle glaucoma; M: month; MAT: microcatheter assisted trabeculotomy; PCG: primary congenital glaucoma.
49 
 1 
Table 6.  Comparison between complete and partial canalization using microcatheter assisted 
trabeculotomy. (*) analyzed in a separate third group; (**) excluded from analysis, considered 
failures; (***) no differentiation between partial MAT and conversion to CT. 
Abbreviations: CS: complete success; CT: conventional trabeculotomy; IOP: intraocular pressure; JOAG: juvenile open angle glaucoma; m: 
month; MAT: microcatheter assisted trabeculotomy; PCG: primary congenital glaucoma; QS: qualified; SCG: secondary congenital glaucoma. 
 
Article Study design 





Total Complete Partial Complete MAT 
Partial 
MAT 


























at both 12 
and 36 
months. 
























MAT vs CT 
33 19 14 0 No info. No info. 
Mean cannulation 
MAT 336º±34 














0 No info. No info. 
No significant difference 
- Postoperative IOP 
- Success rates, p=0.200 




MAT vs CT 






Overall (complete + 
partial MAT) 
CS 80% QS 90% 


































No significant difference 
IOP reduction complete 
vs partial MAT, p=0.950 
 
Positive correlation 
postoperative IOP and 
MAT extent (r=0.180, 
p=0.260) 
Shi et al.27 
Childhood 
glaucoma 
























Need for medication was 


























11 6 5 0 No info. No info. 
Mean IOP reduction 
complete MAT 60% vs 





MAT vs  
goniotomy 
11 6 5 0 No info. No info. 
Mean IOP reduction 
complete MAT 65% vs 
partial 52%, p=0.090 
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